Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
Iovance Biotherapeutics(IOVA) stock is priced at $2.90, giving the company a market capitalization of 1.16B. It carries a P/E multiple of -2.39.
On 2025-12-25, Iovance Biotherapeutics(IOVA) stock traded between a low of $2.79 and a high of $2.95. Shares are currently priced at $2.90, which is +3.9% above the low and -1.7% below the high.
The Iovance Biotherapeutics(IOVA)'s current trading volume is 7.68M, compared to an average daily volume of 14.55M.
In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $8.15 and a 52-week low of $1.64.
In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $8.15 and a 52-week low of $1.64.
IOVA News
Iovance Biotherapeutics recently strengthened its position by granting inducement stock options to new employees while benefiting from fresh analyst coverage an...
